Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Schizoaffective Disorder”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT00836251
What this trial is testing

Effects of Antipsychotic Medications on Energy Intake and Expenditure

Who this might be right for
SchizophreniaSchizoaffective DisorderWeight Gain
Washington University School of Medicine 15
Large-scale testing (Phase 3)Study completedNCT00159770
What this trial is testing

Effect And Safety Of Ziprasidone Compared To Other Atypical Antipsychotic Drug In Schizophrenic Patients

Who this might be right for
SchizophreniaSchizoaffective DisorderPsychotic Disorders
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 290
Very early researchStudy completedNCT01519557
What this trial is testing

Pharmacologic and Clinical Testing of a D1 Agonist for Cognitive Enhancement in Neuropsychiatric Disorders

Who this might be right for
SchizophreniaSchizoaffective Disorder
New York State Psychiatric Institute 68
Large-scale testing (Phase 3)Study completedNCT00714818
What this trial is testing

Impact of Genetic Counseling for Female First Degree Relatives of Individuals With Mental Illness

Who this might be right for
SchizophreniaBipolar DisorderSchizoaffective Disorder
University of British Columbia 13
Not applicableStudy completedNCT07005245
What this trial is testing

Survey on the Reproductive and Child-Rearing Situations of Patients With Severe Mental Disorders

Who this might be right for
Schizophrenia and Schizoaffective DisorderBipolar Disorder (BD)
Peking University 77,145
Not applicableStudy completedNCT00135772
What this trial is testing

Nicotine and Cotinine Levels in Smokers With Schizophrenia and Schizoaffective Disorder - 2

Who this might be right for
Schizophrenia and Disorders With Psychotic FeaturesTobacco Use Disorder
National Institute on Drug Abuse (NIDA) 100
Not applicableStudy completedNCT00222495
What this trial is testing

A Comparative Study of New Medications for Psychosis in Adolescents

Who this might be right for
Psychotic DisordersSchizophreniaSchizophreniform Disorders+1 more
University of Minnesota 30
Testing effectiveness (Phase 2)Temporarily pausedNCT05567848
What this trial is testing

Accelerated TMS in Psychosis

Who this might be right for
SchizophreniaSchizoaffective DisorderProdromal Schizophrenia
Beth Israel Deaconess Medical Center 20
Not applicableStudy completedNCT00169052
What this trial is testing

Health Care Management and Rehabilitation Skills Training for Treating Serious Mental Illness in Older People

Who this might be right for
SchizophreniaSchizoaffective DisorderBipolar Disorder+1 more
Dartmouth-Hitchcock Medical Center 180
Testing effectiveness (Phase 2)Study completedNCT02230384
What this trial is testing

Novel Smoking Cessation Drug for Schizophrenia

Who this might be right for
Smoking Cessation
K.N. Roy Chengappa 62
Not applicableStudy completedNCT05633108
What this trial is testing

A Study Based on the French National Health Insurance Database in Participants With Psychotic Disorders

Who this might be right for
Psychotic Disorders
Eisai Co., Ltd. 579,728
Large-scale testing (Phase 3)Study completedNCT04268303
What this trial is testing

Dexmedetomidine in the Treatment of Agitation Associated With Schizophrenia

Who this might be right for
AgitationSchizophreniaSchizo Affective Disorder+2 more
BioXcel Therapeutics Inc 380
Large-scale testing (Phase 3)Study completedNCT01121042
What this trial is testing

Double Blind, Placebo-Controlled, Randomised Investigation of Ondansetron in Schizophrenia

Who this might be right for
Schizoaffective and Schizophreniform DisordersSchizophrenia
Bayside Health 85
Early research (Phase 1)Ended earlyNCT01568203
What this trial is testing

First-in-Human Study to Evaluate AMG 579 in Healthy Subjects and Patients With Stable Schizophrenia

Who this might be right for
Schizophrenia
Amgen 50
Not applicableWithdrawnNCT05338424
What this trial is testing

Exercise Target Brain Oscillations in Psychosis

Who this might be right for
PsychosisSchizophreniaSchizoaffective Disorder
University of Minnesota
Testing effectiveness (Phase 2)Study completedNCT00167310
What this trial is testing

Decreasing Risk of Coronary Artery Disease in Schizophrenia by Omega-3 Fatty Acid Supplementation

Who this might be right for
SchizophreniaSchizoaffective DisorderMajor Depression+2 more
University of Pittsburgh 57
Early research (Phase 1)Study completedNCT01116830
What this trial is testing

The Effect of RO4917838 on Biomarker Measures of Cognitive Dysfunction in Participants With Schizophrenia and Schizoaffective Disorder

Who this might be right for
Schizophrenia
Hoffmann-La Roche 29
Not applicableActive Not RecruitingNCT06474195
What this trial is testing

Cue-based Intervention in Prospective Memory and Medication Adherence.

Who this might be right for
Schizophrenia
University of Pittsburgh 104
Not applicableNot Yet RecruitingNCT07659938
What this trial is testing

Frontal Gamma Coherence Neurofeedback for Patients With Schizophrenia

Who this might be right for
SchizophreniaSchizoaffective
BioSignal Solutions LLC 30
Post-approval studies (Phase 4)Study completedNCT00313391
What this trial is testing

Risperdal Consta and Health Care Utilization in Patients With Schizophrenia

Who this might be right for
SchizophreniaSchizoaffective Disorder
Emory University
Next Page